ALT "Genetically profiling all patients' cancers to detect biomarkers can help improve treatment. Access to biomarker tests to guide personalised care varies across different parts of the UK, so patients may be missing out. Testing should be increased and multiple biomarkers assessed at once to match patients to the best treatment. Targeting therapies to patients who are most likely to response would improve outcomes and be more cost-effective."